JAKARTA, March 15 (Reuters): Indonesia will delay the administering of AstraZeneca's Covid-19 vaccine due to reports of blood clots among some recipients in Europe and would await a review from the World Health Organisation (WHO), its health minister said on Monday.
The European Medicines Agency has said there is no indication that the events were caused by the vaccination, a view echoed Friday by the WHO, while AstraZeneca said on Sunday its review has shown no evidence of an increased risk of blood clots.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
